Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Oct. 28, 2023
Abstract
Background
The
burden
of
the
COVID-19
pandemic
in
terms
morbidity
and
mortality
differentially
affected
populations.
Between
within
populations,
behaviour
change
was
likewise
heterogeneous.
Factors
influencing
precautionary
adoption
during
have
been
associated
with
multi-dimensional
aspects
risk
perception;
however,
influence
lived
experiences
other
recent
outbreaks
on
has
less
studied.
Methods
To
consider
how
direct
disease
experience
(‘near
misses’)
2014–2016
Ebola
virus
(EVD)
outbreak
may
impacted
early
waves
West
Africa,
we
analyzed
data
from
a
mixed-methods
study
that
included
phone-based
survey
in-depth
interviews
among
vaccinated
Liberian
adults.
Logistic
regression
via
generalized
estimating
equations
QIC-based
model
selection
conducted
to
evaluate
interaction
between
individual
effects
(EVD
COVID-19)
‘near
miss’
behaviours.
Thematic
analysis
interview
transcripts
explored
reasons
for
differential
two
outbreaks.
Results
At
population
level,
being
not
significantly
different
behavior
versus
Ebola;
overall,
people
had
lower
odds
adopting
behaviors
relative
Ebola.
Qualitatively,
participants
often
reflected
themes
around
more
proximal
personal
than
COVID-19;
they
also
commented
EVD
led
better
preparedness
at
systems
level
communities
behave
an
outbreak,
despite
such
awareness
necessarily
translating
into
action
COVID-19.
Conclusion
results
suggest
perceived
proximity
intensity
threats
space
time
affects
behavioural
decisions.
For
successive
threats,
comparisons
present
past
compound
those
effects,
regardless
whether
individuals
directly
experience.
Measures,
as
communication
community
engagement
efforts,
gauge
reflect
previous
should
be
considered
response
strategies
enhance
adoption.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Aug. 6, 2023
Abstract
Background
Diagnosis
of
SARS-CoV-2
infection
in
Liberia
has
primarily
relied
on
polymerase
chain
reaction
(PCR)-based
testing
at
the
country’s
National
Reference
Laboratory.
This
centralized
approach
caused
reporting
delays,
prompting
evaluation
point-of-care
antigen-based
tests.
We
assessed
test
performance
LumiraDx™
Ag
(LumiraDx™,
London,
UK)
this
setting.
Methods
tested
ambulatory
individuals
screened
for
enrollment
into
an
observational
cohort
study
COVID-19
sequelae
Monrovia
2021.
compared
results
LumiraDx
anterior
nasal
swab
specimens
to
PCR
BioFire®
R2.1P
(bioMérieux,
Salt
Lake
City,
Utah)
eluent
from
nasopharyngeal
swabs.
Results
evaluated
348
individuals.
Among
274
persons
with
symptoms,
49.3%
were
PCR-positive
and
36.5%
antigen-positive.
The
sensitivity,
specificity,
negative
predictive
value
(NPV),
positive
(PPV)
group
72.6%
(95%
CI:
64.3%-79.9%),
98.6%
94.9%-99.8%),
78.7%
(CI:
71.9%-84.6%),
98.0%
93.0%-99.8%),
respectively.
74
asymptomatic
individuals,
12.2%
by
PCR,
5.5%
antigen
testing,
resulting
a
NPV,
PPV
44.4%
13.7%-78.8%),
100%
94.5%-100%),
92.9%
84.1%-97.6%),
39.8%-100%),
Conclusion
Although
specificity
diagnosing
high
among
without
sensitivity
was
unacceptably
low
both
groups,
much
less
than
that
reported
manufacturer.
Before
new
diagnostics
are
adopted,
needs
be
local
Wellcome Open Research,
Journal Year:
2023,
Volume and Issue:
8, P. 350 - 350
Published: Aug. 17, 2023
Background:
Given
the
low
levels
of
coronavirus
disease
2019
(COVID-19)
vaccine
coverage
in
sub-Saharan
Africa
(sSA),
despite
high
natural
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2)
exposures,
strategies
for
extending
breadth
and
longevity
naturally
acquired
immunity
are
warranted.
Designing
such
will
require
a
good
understanding
immunity.Methods:
We
measured
whole-spike
immunoglobulin
G
(IgG)
spike-receptor
binding
domain
(RBD)
total
immunoglobulins
(Igs)
on
585
plasma
samples
collected
longitudinally
over
five
successive
time
points
within
six
months
COVID-19
diagnosis
309
patients.
We
antibody-neutralising
potency
against
wild-type
(Wuhan)
SARS-CoV-2
pseudovirus
subset
51
patients
three
points.
Binding
neutralising
antibody
potencies
were
then
tested
correlations
with
severities.Results:
Rates
seroconversion
increased
from
day
0
(day
PCR
testing)
to
180
(six
months)(63.6%
100
%)
(69.3
%
97%)
anti-spike-IgG
anti-spike-RBD
Igs,
respectively.
Levels
these
antibodies
peaked
at
28
(p<0.0001)
subsequently
maintained
without
significant
decay
(p>0.99).
Similarly,
but
declined
by
three-fold,
after
(p<0.0001).
highly
correlated
neutralisingantibody
all
analysed
(r>0.6,
p<0.0001).
severity.Conclusions:
Most
generated
specific
that
remained
stable
first
infection.
However,
respective
decayed
three-fold
month-six
suggesting
they
short-lived,
consistent
what
has
been
observed
elsewhere
world.
Thus,
regular
vaccination
boosters
required
sustain
anti-SARS-CoV-2
our
population.
Ghana
and
other
parts
of
West
Africa
have
experienced
significantly
lower
mortality
rates
from
COVID-19
in
comparison
to
regions.
This
phenomenon
has
been
attributed
previous
exposure
infections
such
as
malaria.
study
was
conducted
investigate
the
SARS-CoV-2
immune
response
impact
malaria
Ghana.
Blood
samples
were
collected
(n=217)
individuals
who
had
classified
either
asymptomatic
or
symptomatic.
Serology
assays
utilized
evaluate
phenotype,
specific
responses,
while
P.
falciparum-specific
antibodies
quantified
using
ELISA.
The
found
evidence
attenuated
responses
among
individuals,
with
elevated
proportions
non-classical
monocytes
greater
memory
B-cell
activation.
Symptomatic
patients
displayed
higher
T-cell
recall
demonstrated
falciparum
antibody
levels.
concludes
that
exposure-associated
modulation
may
contribute
reduced
severity
people
living
malaria-endemic
Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Oct. 28, 2023
Abstract
Background
The
burden
of
the
COVID-19
pandemic
in
terms
morbidity
and
mortality
differentially
affected
populations.
Between
within
populations,
behaviour
change
was
likewise
heterogeneous.
Factors
influencing
precautionary
adoption
during
have
been
associated
with
multi-dimensional
aspects
risk
perception;
however,
influence
lived
experiences
other
recent
outbreaks
on
has
less
studied.
Methods
To
consider
how
direct
disease
experience
(‘near
misses’)
2014–2016
Ebola
virus
(EVD)
outbreak
may
impacted
early
waves
West
Africa,
we
analyzed
data
from
a
mixed-methods
study
that
included
phone-based
survey
in-depth
interviews
among
vaccinated
Liberian
adults.
Logistic
regression
via
generalized
estimating
equations
QIC-based
model
selection
conducted
to
evaluate
interaction
between
individual
effects
(EVD
COVID-19)
‘near
miss’
behaviours.
Thematic
analysis
interview
transcripts
explored
reasons
for
differential
two
outbreaks.
Results
At
population
level,
being
not
significantly
different
behavior
versus
Ebola;
overall,
people
had
lower
odds
adopting
behaviors
relative
Ebola.
Qualitatively,
participants
often
reflected
themes
around
more
proximal
personal
than
COVID-19;
they
also
commented
EVD
led
better
preparedness
at
systems
level
communities
behave
an
outbreak,
despite
such
awareness
necessarily
translating
into
action
COVID-19.
Conclusion
results
suggest
perceived
proximity
intensity
threats
space
time
affects
behavioural
decisions.
For
successive
threats,
comparisons
present
past
compound
those
effects,
regardless
whether
individuals
directly
experience.
Measures,
as
communication
community
engagement
efforts,
gauge
reflect
previous
should
be
considered
response
strategies
enhance
adoption.